The ACR has highlighted critical changes for the 2021 performance year outlined in the proposed rule released Aug. 3 by the Centers for Medicare & Medicaid Services.
Articles by From the College
ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner
The conversation with Stephen Hahn, MD, addressed challenges associated with hydroxychloroquine access during the COVID-19 public health emergency and handling patient concerns about potential cardiac side effects.
The ACR Expresses Strong Support for Dr. Anthony Fauci
The ACR, on behalf of its more than 7,700 members of the professional rheumatology community, wishes to express strong support for Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), and his continued and close involvement in the work to address the nation’s response to the COVID-19 pandemic. During…
ACR Updates COVID-19 Clinical Guidance for Adult Patients
Note: This article was updated July 21 to add recommendations on restarting biologics following COVID-19. On April 29, the ACR released Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic and later updated the guidance for publication in Arthritis & Rheumatology. The recommendations address various treatment options and provide general…
Joint Letter to CMS Advocates Against Adding Stelara to Self-Administered Drug List
The ACR, CSRO and Arthritis Foundation asked the Centers for Medicare & Medicaid Services to review the decision to add Stelara to the Self-Administered Drugs list, which would limit access for patients who can’t self-administer.
ACR Releases COVID-19 Clinical Guidance for Pediatric Patients
The ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic.
The ACR on Air Podcast’s COVID-19 Series
In light of the current COVID-19 pandemic, the ACR has dedicated a few episodes of the ACR on Air podcast to the challenges that have arisen, along with information about the available resources and guidance. The first episode in this special series looks at drug shortages surrounding hydroxychloroquine (HCQ) and its initial uses to treat…
The COVID-19 Pandemic & the ACR’s Response
The ACR has been working on many levels to assist the rheumatology community during the COVID-19 pandemic, and we are focusing our efforts on areas critical for rheumatologists and rheumatology professionals, practices and patients. Because the pandemic poses many clinical and economic challenges, the ACR will continue to monitor this fast-paced, ever-changing situation and provide…
Foundation’s Award Provides Research Opportunity for Community-Based Practitioners
Rheumatologists in community-based practices work closely with patients, which allows them to notice trends and nuances researchers may not. Unfortunately, few opportunities exist for rheumatologists to test their observations through research, in addition to taking care of patients. Limited funding, time constraints and competition from larger academic medical centers are some of the barriers that…
Collaborate, Innovate & Learn at ACR Convergence 2020: The ACR’s All-Virtual Annual Meeting
ACR Convergence 2020—the ACR’s annual meeting—will be presented online. Get ready for an innovative experience.
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 94
- Next Page »